πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8883448

Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8877765

Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8877914

Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8877213

Live attenuated Leishmania vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8877199

B cell surface reactive antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8871191

Use of IL-15 preparations to treat lymphopenia

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8871206

Anti-human folate receptor beta antibodies and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8871789

Method of preventing or treating viral infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8871902

Immunogenic POTE peptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8871906

Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865880

Identification of a novel BHD gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865686

Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865461

Rabies virus vector systems and compositions and methods thereof

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865672

Prevention of tissue ischemia and related methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8859585

Scopolamine for the treatment of depression and anxiety

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8858938

Human monoclonal antibodies against Hendra and Nipah viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8858946

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8858930

Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemo

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8858959

Gel vaccine delivery system for treating poultry

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8859207

Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8853160

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8853277

Nitroxide therapy for the treatment of von Hippelβ€”Lindau disease (VHL) and renal clear cel

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8852598

Puumala virus full-length M segment-based DNA vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8852605

Vibrio cholerae O139 conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted